Search Results 121-130 of 16311 for Proto-oncogene
Mayo Clinic Researchers Find Two Oncogenes Join to Drive Lung Squamous Cell Carcinoma. Kevin Punsky. February 10, 2014. First · Previous ... 334 · 335 · 336 ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
Breast anatomy · Ductal cells. Ductal breast cancer, also called ductal carcinoma, is the most common type of breast cancer. · Lobular cells. Lobular breast ...
The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...
... oncogenic potential. Co-authors of the paper include Barbara Schroeder, Ph.D. of Mayo Clinic, Javier Menendez, Catalan, Institute of Oncology, Susan Peirce ...
Treatments such as chemotherapy, hormone therapy and immunotherapy have had limited success against advanced prostate cancer due to the tumor's ability to ...
The Mayo Clinic Breast Cancer SPORE supports translational research projects on genetic mutations, Z-endoxifen and p95HER2 in HER2+ breast cancer.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.